These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 12695884)
1. Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study. Lin AP; Shic F; Enriquez C; Ross BD MAGMA; 2003 Feb; 16(1):29-42. PubMed ID: 12695884 [TBL] [Abstract][Full Text] [Related]
2. ¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease. Doert A; Pilatus U; Zanella F; Müller WE; Eckert GP J Neural Transm (Vienna); 2015 Apr; 122(4):541-50. PubMed ID: 25742870 [TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis. Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632 [TBL] [Abstract][Full Text] [Related]
4. Decreased glutamate + glutamine in Alzheimer's disease detected in vivo with (1)H-MRS at 0.5 T. Antuono PG; Jones JL; Wang Y; Li SJ Neurology; 2001 Mar; 56(6):737-42. PubMed ID: 11274307 [TBL] [Abstract][Full Text] [Related]
5. Clinical experience with 13C MRS in vivo. Ross B; Lin A; Harris K; Bhattacharya P; Schweinsburg B NMR Biomed; 2003; 16(6-7):358-69. PubMed ID: 14679500 [TBL] [Abstract][Full Text] [Related]
7. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease. Wang Z; Zhao C; Yu L; Zhou W; Li K Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582 [TBL] [Abstract][Full Text] [Related]
8. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028 [TBL] [Abstract][Full Text] [Related]
9. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. Waldman AD; Rai GS Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326 [TBL] [Abstract][Full Text] [Related]
10. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease. Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758 [TBL] [Abstract][Full Text] [Related]
11. Reduced hippocampal glutamate in Alzheimer disease. Rupsingh R; Borrie M; Smith M; Wells JL; Bartha R Neurobiol Aging; 2011 May; 32(5):802-10. PubMed ID: 19501936 [TBL] [Abstract][Full Text] [Related]
12. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. Jones RS; Waldman AD Neurol Res; 2004 Jul; 26(5):488-95. PubMed ID: 15265265 [TBL] [Abstract][Full Text] [Related]
13. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis. Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366 [TBL] [Abstract][Full Text] [Related]
14. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment. Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332 [TBL] [Abstract][Full Text] [Related]
15. Brain glutamate levels are decreased in Alzheimer's disease: a magnetic resonance spectroscopy study. Fayed N; Modrego PJ; Rojas-Salinas G; Aguilar K Am J Alzheimers Dis Other Demen; 2011 Sep; 26(6):450-6. PubMed ID: 21921084 [TBL] [Abstract][Full Text] [Related]
16. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study]. Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242 [TBL] [Abstract][Full Text] [Related]
17. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy. Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study. Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314 [TBL] [Abstract][Full Text] [Related]
19. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers. Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247 [TBL] [Abstract][Full Text] [Related]